Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Publication Title

medRxiv

Authors

Daniel R Barnes
Jonathan P Tyrer
Joe Dennis
Goska Leslie
Manjeet K Bolla
Michael Lush
Amber M Aeilts
Kristiina Aittomäki
Nadine Andrieu
Irene L Andrulis
Hoda Anton-Culver
Adalgeir Arason
Banu K Arun
Judith Balmaña
Elisa V Bandera
Rosa B Barkardottir
Lieke P V Berger
Amy Berrington de Gonzalez
Pascaline Berthet
Katarzyna Białkowska
Line Bjørge
Amie M Blanco
Marinus J Blok
Kristie A Bobolis
Natalia V Bogdanova
James D Brenton
Henriett Butz
Saundra S Buys
Maria A Caligo
Ian Campbell
Carmen Castillo
Kathleen B M Claes
Sarah V Colonna
Linda S Cook
Mary B Daly
Agnieszka Dansonka-Mieszkowska
Miguel de la Hoya
Anna deFazio
Allison DePersia
Yuan Chun Ding
Susan M Domchek
Thilo Dörk
Zakaria Einbeigi
Christoph Engel
D Gareth Evans
Lenka Foretova
Renée T Fortner
Florentia Fostira
Maria Cristina Foti
Eitan Friedman
Megan N Frone
Patricia A Ganz
Aleksandra Gentry-Maharaj
Gord Glendon
Andrew K Godwin
Anna González-Neira
Mark H Greene
Jacek Gronwald
Aliana Guerrieri-Gonzaga
Ute Hamann
Thomas V O Hansen
Holly R Harris
Jan Hauke
Florian Heitz
Frans B L Hogervorst
Maartje J Hooning
John L Hopper
Chad D Huff
David G Huntsman
Evgeny N Imyanitov
Louise Izatt
Anna Jakubowska
Paul A James
Ramunas Janavicius
Esther M John
Siddhartha Kar
Beth Y Karlan
Catherine J Kennedy
Lambertus A L M Kiemeney
Irene Konstantopoulou
Jolanta Kupryjanczyk
Yael Laitman
Ofer Lavie
Kate Lawrenson
Jenny Lester
Fabienne Lesueur
Carlos Lopez-Pleguezuelos
Phuong L Mai
Siranoush Manoukian
Taymaa May
Iain A McNeish
Usha Menon
Roger L Milne
Francesmary Modugno
Jennifer M Mongiovi
Marco Montagna
Kirsten B Moysich
Susan L Neuhausen
Finn C Nielsen
Catherine Noguès
Edit Oláh
Olufunmilayo I Olopade
Ana Osorio
Laura Papi
Harsh Pathak
Celeste L Pearce
Inge S Pedersen
Ana Peixoto
Tanja Pejovic, Department of Obstetrics & Gynecology, Providence Medical Center, Medford, OR, USA., Providence Cancer Center, Medford, OR, USA.Follow
Pei-Chen Peng
Beth N Peshkin
Paolo Peterlongo
C Bethan Powell
Darya Prokofyeva
Miquel Angel Pujana
Paolo Radice
Muhammad U Rashid
Gad Rennert
George Richenberg
Dale P Sandler
Naoko Sasamoto
Veronica W Setiawan
Priyanka Sharma
Weiva Sieh
Christian F Singer
Katie Snape
Anna P Sokolenko
Penny Soucy
Melissa C Southey
Dominique Stoppa-Lyonnet
Rebecca Sutphen
Christian Sutter
Manuel R Teixeira
Kathryn L Terry
Liv Cecilie V Thomsen
Marc Tischkowitz
Amanda E Toland
Toon Van Gorp
Ana Vega
Digna R Velez Edwards
Penelope M Webb
Jeffrey N Weitzel
Nicolas Wentzensen
Alice S Whittemore
Stacey J Winham
Anna H Wu
Siddhartha Yadav
Yao Yu
Argyrios Ziogas
Andrew Berchuck
Fergus J Couch
Ellen L Goode
Marc T Goodman
Alvaro N Monteiro
Kenneth Offit
Susan J Ramus
Harvey A Risch
Joellen M Schildkraut
Mads Thomassen
Jacques Simard
Douglas F Easton
Michelle R Jones
Georgia Chenevix-Trench
Simon A Gayther
Antonis C Antoniou
Paul D P Pharoah

Document Type

Article

Publication Date

3-4-2024

Keywords

oregon; medford; genomics

Abstract

BACKGROUND: Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We used data from the Ovarian Cancer Association Consortium (OCAC), Consortium of Investigators of Modifiers of

METHODS: We analyzed >22 million variants for 398,238 women. Associations were assessed separately by consortium and meta-analysed. OCAC and CIMBA data were used to develop PGS which were trained on FinnGen data and validated in UKBB and BioBank Japan.

RESULTS: Eight novel variants were associated with HGSOC risk. An interesting discovery biologically was finding that

CONCLUSIONS: This study represents the largest GWAS for HGSOC to date. The results highlight that improvements in imputation reference panels and increased sample sizes can identify HGSOC associated variants that previously went undetected, resulting in improved PGS. The use of updated PGS in cancer risk prediction algorithms will then improve personalized risk prediction for HGSOC.

Clinical Institute

Women & Children

Clinical Institute

Cancer

Specialty/Research Institute

Obstetrics & Gynecology

Specialty/Research Institute

Oncology

Specialty/Research Institute

Epidemiology

DOI

10.1101/2024.02.29.24303243

Share

COinS